SCHEMBL30952425

SCHEMBL30952425

CC(C)(C)OC(=O)N1CCC[C@@H](Nc2nnc(Cl)c3ccc(C#N)cc23)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.51
GPR119 Q8TDV5 5/20 0.46
PIK3CD O00329 2/20 0.44
NSD2 O96028 1/20 0.44
USP30 Q70CQ3 2/20 0.43
PIM1 P11309 2/20 0.41
PIM2 Q9P1W9 2/20 0.41
BTK Q06187 2/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40
CLK1 P49759 1/20 0.40
CLK2 P49760 1/20 0.40
CDK7 P50613 1/20 0.40
CDK9 P50750 1/20 0.40
IRAK1 P51617 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
PARP1 P09874 1/20 0.40
PDE5A O76074 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27356051 0.88 USP30 (0.45) PIK3CDUSP30PIM1PIM2BTK
SCHEMBL31043412 0.88 USP30 (0.45) PIK3CDUSP30PIM1PIM2BTK
SCHEMBL30108729 0.85 USP30 (0.50) PIK3CDUSP30PIM1PIM2BTK
SCHEMBL27354366 0.85 USP30 (0.50) PIK3CDUSP30PIM1PIM2BTK
SCHEMBL25858601 0.85 USP30 (0.50) PIK3CDUSP30PIM1PIM2BTK
SCHEMBL31719414 0.85 IRAK4 (0.47) IRAK4PIK3CDPDE5AKDM1A
SCHEMBL31043425 0.84 USP30 (0.45) PIK3CDUSP30PIM1PIM2BTK
SCHEMBL27356058 0.84 USP30 (0.45) PIK3CDUSP30PIM1PIM2BTK
SCHEMBL30624719 0.82 USP30 (0.43) PIK3CDUSP30PIM1PIM2BTK
SCHEMBL29131908 0.82 USP30 (0.43) PIK3CDUSP30PIM1PIM2BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4644380-A1 PYRIDAZINE NLRP3 INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF Changchun Genescience Pharmaceutical Co., Ltd. (CN) 2025-11-05 EP disclosed
WO-2024140824-A1 PYRIDAZINE NLRP3 INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF 长春金赛药业有限责任公司 2024-07-04 WO disclosed